ArticleAIDS and behavior2026
Awareness, Willingness, and Use of Doxycycline Post-Exposure Prophylaxis Among Men Who Have Sex with Men in Taiwan.
Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Doxycycline post-exposure prophylaxis (doxyPEP) engagement-awareness, willingness, and use-for bacterial sexually transmitted infection (STI) prevention remains understudied in Taiwan. This secondary analysis used logistic regression to examine doxyPEP engagement and its correlates among 1,654 men who have sex with men (MSM) in Taiwan (November-December 2023). Awareness, willingness, and use were reported by 24.4%, 33.0%, and 2.9% of participants, respectively. Awareness, willingness, and use were greater among MSM not living with HIV and taking PrEP and MSM living with HIV than among MSM not living with HIV and not taking PrEP. Bacterial STI diagnosis was associated with greater willingness and use; age ≥ 40 years, condomless anal sex, and receipt of ≥ 1 mpox vaccine dose were also associated with greater willingness. These findings suggest that PrEP and HIV treatment services and bacterial STI screening and treatment encounters may offer opportunities for doxyPEP delivery, while additional strategies may be needed to reach MSM not routinely engaged in these services.
Identifiers
42886306What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.